Arrakis Therapeutics vs Moderna
Arrakis Therapeutics vs Moderna, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Arrakis Therapeutics is on 46/100 and Moderna on 77/100.
Where each one leads
Arrakis Therapeutics
Leads on none of the measures we hold for both companies.
Moderna
- our overall score: 77/100 against 46/100
- agent readiness: 49/100 against 37/100
- domain rating: 79/100 against 29/100
- headcount: 6,297 against 52
- LinkedIn following: 780,086 against 12,956
At a glance
| Measure | Arrakis Therapeutics | Moderna |
|---|---|---|
| What it is | Arrakis Therapeutics is a biopharmaceutical company developing oral medicines that target RNA to treat a range of diseases. The company is based in Waltham, Mas | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. |
| Category | Biotech, Drug Discovery, RNA Therapeutics, Small Molecule Drugs | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2014 | 2010 |
| Headquarters | Waltham, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Arrakis Therapeutics | Moderna |
|---|---|---|
| Employees | 52 | 6,297 |
| Open roles | Not published | 100 |
| Total funding | Not published | $4.5B |
| Latest round | Not published | Funding Round |
| LinkedIn followers | 12,956 | 780,086 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Arrakis Therapeutics | Moderna |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 46/100 | 77/100 |
| Traction | 17/100 | 60/100 |
| Team | Not published | 70/100 |
| Community | Not published | 13/100 |
| Search visibility | 34/100 | 46/100 |
| Quality | 68/100 | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 29/100 | 79/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Arrakis Therapeutics | Moderna |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | CloudFront |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Next.js |
| Analytics | Google Analytics 4 | Not detected |
What users say
| Measure | Arrakis Therapeutics | Moderna |
|---|---|---|
| Community ratingVisitor votes on StartupHub | Not published | 2.0/5 from 1 vote |
| Reddit sentimentThreads we track | 2 positive, 2 negative across 4 threads | Not published |
“Pharmaunternehmen - Roche schliesst Lizenzvereinbarung mit Arrakis Therapeutics, Der Pharmakonzern Roche hat sich auf eine Lizenzvereinbarung mit dem US-Biotechunternehmen Arrakis Therapeutics geeinigt..”r/chpresseschau
Arrakis Therapeutics vs Moderna: common questions
Which is better, Arrakis Therapeutics or Moderna?
On our 0-100 score Moderna rates higher (77/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Arrakis Therapeutics and Moderna compare on the numbers?
Moderna leads on our overall score (77/100 against 46/100), agent readiness (49/100 against 37/100), domain rating (79/100 against 29/100), headcount (6,297 against 52), LinkedIn following (780,086 against 12,956).
What do real users say about Arrakis Therapeutics and Moderna?
Arrakis Therapeutics: 2 positive and 2 negative mentions across 4 Reddit threads we track, mostly in r/chpresseschau.
Read the full Arrakis Therapeutics review and pricing or the Moderna review and pricing. You can also browse other Arrakis Therapeutics alternatives we track.